Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965185 | Vaccine | 2014 | 7 Pages |
Abstract
The increased product yields that can easily be reached using these higher cell density cultivation methods, showed the possibility for better use of bioreactor capacity for the manufacturing of polio vaccines to ultimately reduce vaccine cost per dose. Further, the use of animal-component-free cell- and virus culture media shows opportunities for modernization of human viral vaccine manufacturing.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yvonne E. Thomassen, Olaf Rubingh, René H. Wijffels, Leo A. van der Pol, Wilfried A.M. Bakker,